These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
2 files

In Vitro and In Vivo Sequestration of Phencyclidine by Me4Cucurbit[8]uril

submitted on 23.09.2020, 14:10 and posted on 25.09.2020, 07:42 by Steven Murkli, Jared Klemm, Adam T. Brockett, Michael Shuster, Volker Briken, Matthew R. Roesch, Lyle Isaacs
This work describes the in vitro binding of CB[8] and Me4CB[8] toward a panel of 10 drugs of abuse, and in vitro and in vivo assays to demonstrate the biocompatibility of Me4CB[8]. In vivo efficacy studies show that Me4CB[8] can control the hyper locomotion of animals treated with PCP.


National Institutes of Health (GM132345 and CA168365)

National Science Foundation (CHE-1404911)

Department of Education (GAANN, P200A150033)


Email Address of Submitting Author


University of Maryland, College Park


United States

ORCID For Submitting Author


Declaration of Conflict of Interest

The University of Maryland has filed a patent on the material presented in this paper with S.M. and L.I. named as inventors.